26.0
[U/l]
ALT
12.0
[U/l]
AST
1.7
mg/l
C-reactive protein
1063.0
µg/l FEU
D-dimer
2025-08-18
ENA first public
ERC000015
ENA-CHECKLIST
SAMEA114291185
External Id
Malopolska Centre of Biotechnology
INSDC center name
2023-08-18T13:40:32Z
INSDC last update
public
INSDC status
290.0
U/l
LDH (L)
ERS16280302
SRA accession
deep316
Submitter Id
not provided
alcohol consumption frequency
no
allergy
no
antibiotic treatment during hospitalization
1 month
antibiotics before hospital
material anatomical entity
broad-scale environmental context
2021-01-01
collection date
no
death
Human gut metagenome sample
description
yes
diabetes
type II diabetes
diabetes type
feces
environmental medium
White
ethnicity
445.0
ng/ml
ferritin
Poland
geographic location (country and/or sea)
52.24
DD
geographic location (latitude)
21.02
DD
geographic location (longitude)
CSK
hospital
stool
host body product
intestine
host body site
20.7
kg/m2
host body-mass index
163
cm
host height
female
host sex
140
host subject id
yes
hypertension
no
icu
18.6
pg/ml
interleukin-6
organism substance
local environmental context
blood
location of the tumour
not provided
medications dose
Polish
nationality
human gut metagenome
organism
yes
other medical conditions
yes
other medications
Gut Microbiome Dynamics and Predictive Value in Hospitalized COVID-19 Patients: A Comparative Analysis of Shallow and Deep Shotgun Sequencing
project name
77.2
%
sample human DNA contamination
-20
°C
sample storage temperature
human gut metagenome
scientific_name
not provided
seasonal allergy
Illumina NovaSeq 6000
sequencing method
no
smoker
never
smoking frequency
patient (case)
subject type
140_01012021
title
yes
tumour